Elevated body mass index and metabolic disorders, as well as antiphospholipid<unk> , significantly increase the risk of<unk>  in all female patients. Females who have had or are related to a female with previous<unk>  complications tend to be at a higher risk in all their subsequent pregnancies. The risk of<unk>  is not conclusively associated with a specific genetic variation, but likely a combination of genetic variations, such as FAS gene, VEGF gene, glucocorticoid receptor gene and the tol-like receptor gene, increase the risk.
HELLP syndrome
Thrombotic thrombocytopenic purpura
Acute fatty liver of pregnancy
Viral hepatitis
Primrose syndrome
Ascending cholangitis
Antiphospholipid syndrome
Hemolytic–uremic syndrome